Pemazyre™ (pemigatinib) for the Treatment of Cholangiocarcinoma

Image 1-Pemazyre (pemigatinib)
PemazyreTM (pemigatinib) is the first and only FDA approved FGFR inhibitor indicated for the treatment of Cholangiocarcinoma. Credit: Incyte Corporation.